Nov. 9, 2022: PE Firms Invest in Landscaping, Pharmaceuticals and Logistics

Read the top headlines for Wednesday, November 9, 2022 below:

Outdoor Living Supply, Backed by Trilantic, Acquires LandCare

Outdoor Living Supply, an outdoor living products distribution platform backed by middle-market private equity firm Trilantic Capital Management, has announced its latest acquisition. The company is investing in LandCare Associates, an industry peer that distributes hardscape and landscape supplies across New England. According to its press release, Outdoor Living’s geographic reach will expand as a result of the acquisition, while also broadening its supplier base.

GHO Capital, The Vistria Group Pair Up for Pharmaceutical Acquisition

Healthcare investors Global Healthcare Opportunities (GHO Capital Partners) and middle-market private investment firm The Vistria Group have announced their acquisition of a controlling stake in Alcami Corporation, a pharmaceutical contract development and manufacturing organization (CDMO), according to a recent press release.

Their investment follows the decision by Madison Dearborn Partners and Ampersand Capital Partners to exit the business, which facilitates a variety of functions throughout the drug development lifecycle. In a statement, The Vistria Group senior partner and co-head of healthcare said Alcami is “the ideal platform in the CDMO and lab services areas we have been targeting.”

Southfield’s Alba Acquires Logistics Brokerage

Southfield Capital, a lower-middle market private equity firm, announced that its portfolio company, logistics business Alba Wheels Up, has acquired logistics brokerage business KSI Corp. KSI specializes in biotech and semiconductor end-markets, according to the announcement. In a statement, Alba CEO Damien Stile said, “The acquisition of KSI strategic complements our success in a number of other verticals where Alba is a nationally-recognized category leader.”

Alba currently focuses its logistics services on the apparel, home furnishings and medical devices spaces. “The expansion into semiconductors and biotech will be end-markets where Alba can leverage their capabilities to grow its market share and provide additional services,” noted Southfield partner Heb James in another statement.

Comments are closed.